Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san diego blog main
san diego top stories
3
×
boston blog main
boston top stories
fda
abide therapeutics
accent therapeutics
aducanumab
allergan
alzheimer's disease
amblyotech
amylin pharmaceuticals
asklepios biopharmaceutical
ben cravatt
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
boston
botox
boulder/denver blog main
boulder/denver top stories
brainvectis
bristol-myers squibb
c. greg guyer
cancer
cara therapeutics
clinical trials
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
dyne therapeutics
epilepsy
esperion
europe blog main
What
developing
3
×
medicines
3
×
ipo
therapeutics
abide
activity
appointed
approvals
bio
biogen
brings
chief
clamped
company
covid
delays
diseases
disorders
drug
dyne
dyne’s
economic
executive
fast
fda
finney
genetic
including
isn’t
kevin
lot
million
muscle
muscular
neurological
new
officer
operating
oric’s
preclinical
Language
unset
Current search:
medicines
×
developing
×
" san diego top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
